LQDA Liquidia Corporation Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
13:41
Aug 23
Aug 23
Closed LQDA short position
Author closed his LQDA short position. He previously profited from the move from $90 to $69 but has now exited the trade entirely.
LOW
13:21
Aug 17
Aug 17
Q2 flow shows specialists selling
Author maintains a short position, noting that Q2 flow data confirms the thesis as specialists were net sellers.
MED
02:38
Aug 16
Aug 16
Short LQDA, thesis still playing out
Author is actively short LQDA with a plan to cover near $85 and re-short, citing a thesis with time remaining to play out; explicit short position with defined re-entry strategy.
MED
20:04
Aug 13
Aug 13
Author complains their short book is underperforming while longs dominate.
Author complains their short book is underperforming while longs dominate, listing prior short candidates as context rather than fresh trade calls.
15:33
Aug 13
Aug 13
LQDA short: script plateau, terminal patient attrition
Short LQDA because script volumes have been flat at ~450-470/month all year, revenue growth is driven by chronic patient stacking rather than new patient capture, and PH-ILD's brutal 3-year survival rate creates a structural ceiling — steady state arrives when adds equal attrition, making the growth story terminal; $65 price target cited.
HIGH
04:20
Aug 13
Aug 13
Needham raised its target price on Liquidia Corporation to 110 dollars from 70 dollars.
Needham raised its target price on Liquidia Corporation to 110 dollars from 70 dollars, indicating a bullish outlook on the stock.
03:52
Aug 13
Aug 13
Jefferies raised its target price on Liquidia Corporation to 115 dollars from 60 dollars.
Jefferies raised its target price on Liquidia Corporation to 115 dollars from 60 dollars, indicating a bullish outlook.
10:47
Aug 12
Aug 12
LQDA flagged near top, short candidate
Short LQDA as part of an explicitly flagged short-selling list; author signals the stock is near a peak, implying limited upside and downside risk from current levels.
MED
17:25
Aug 10
Aug 10
Highlights past successful biotech valuation calls.
Author lists numerous biotech and pharma tickers as past successful valuation calls, offering no current directional view.
LOW
17:44
May 07
May 07
The author lays out a concentrated long biotech portfolio on a down XBI day.
The author lays out a concentrated long biotech portfolio on a down XBI day, highlighting ABVX as a major position and listing other names under consideration, reflecting a bullish sector outlook despite short-term losses.
HIGH
18:29
Mar 15
Mar 15
The author provides a routine portfolio update detailing additions, reductions.
The author provides a routine portfolio update detailing additions, reductions, and closures across various biotech stocks.
About LQDA Analyst Coverage
Buzzberg tracks LQDA (Liquidia Corporation) across 2 sources. 2 bullish vs 4 bearish calls from 2 analysts. Sentiment: mixed to bearish. 11 total trade ideas tracked. Latest voices: seedy19tron, FirstSquawk.